Administrative Core The goals of Administration and Senior Leadership of the University of Arizona Cancer Center (UACC) are to define the vision of the Center and to create an environment that sustains this vision. The specific goals of Administration are to provide reliable, value-creating administrative, information technology, and decision- making support services that advance the UACC's research mission and to ensure that resources are optimally allocated to further the Center's vision and values. These goals are achieved by providing a Senior Leadership team with exceptional expertise and vision, strong strategic planning skills, and the ability to mobilize the support required to bring initiatives to fruition and by providing administrative support for the planning and implementation of the initiatives identified by the Director and Senior Leadership team as well as its governance activities. In support of the UACC's research mission, Administration is charged with coordinating Center activities, integrating them within the institutional structure, ensuring effective communication among all stakeholders, and providing administrative support and oversight in the areas of Informatics, Finance, Clinical Trials, Communications, Human Resources, Research Administration, Facilities, and Development in support of UACC research. Additionally, Administration provides management, oversight, and coordination of the resources that support the activities of the membership including Shared Resources, facilities, space, and pilot funding opportunities. Administration also supports and facilitates the efforts of the UACC Members to address the needs of the catchment area and its outreach activities, including the initiatives that address the needs of the Hispanic community, the Native American tribes, and the elderly. Finally, it provides administrative support for the portfolio of training activities at the UACC, which are characterized by both their multidisciplinary nature and their inclusiveness. The Director, Deputy Director-Phoenix, and seven Associate Directors comprise Senior Leadership. These individuals are responsible for the development of the basic, translational, and clinical sciences within the Center and the implementation of strategies that advance early scientific findings. Specifically, they work together to: 1) advance cancer research from basic science to clinical and community intervention using precision medicine, 2) further build on UACC's rich history of population studies and behavioral research to address and reduce the cancer burden in minority and underserved populations, 3) effectively serve the UACC's catchment area through service, research, and outreach, and 4) train the next generation of cancer researchers. Senior Leadership is charged with establishing a vision for the Center and addressing overall Center goals, policies, and operations. It evaluates the Programs and Shared Resources, designs and implements the Strategic Plan for the UACC, and assists the Director in developing targeted recruitment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023074-39
Application #
9735123
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
2019-07-01
Project End
2021-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
39
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Hsu, Chiu-Hsieh; Yu, Mandi (2018) Cox regression analysis with missing covariates via nonparametric multiple imputation. Stat Methods Med Res :962280218772592
Agasid, Mark T; Wang, Xuemin; Huang, Yiding et al. (2018) Expression, purification, and electrophysiological characterization of a recombinant, fluorescent Kir6.2 in mammalian cells. Protein Expr Purif 146:61-68
Wales, Jessica A; Chen, Cheng-Yu; Breci, Linda et al. (2018) Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase. J Biol Chem 293:1850-1864
Bell, Melanie L (2018) New guidance to improve sample size calculations for trials: eliciting the target difference. Trials 19:605
Lindeman, Leila R; Randtke, Edward A; High, Rachel A et al. (2018) A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH. Magn Reson Med 79:2766-2772
Remeniuk, Bethany; King, Tamara; Sukhtankar, Devki et al. (2018) Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain. Pain 159:684-698
Goldenberg, Joshua M; Pagel, Mark D; Cárdenas-Rodríguez, Julio (2018) Characterization of D-maltose as a T2 -exchange contrast agent for dynamic contrast-enhanced MRI. Magn Reson Med 80:1158-1164
Blohm-Mangone, Karen; Burkett, Nichole B; Tahsin, Shekha et al. (2018) Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 Mice. Cancer Prev Res (Phila) 11:265-278
Tao, Shasha; Rojo de la Vega, Montserrat; Chapman, Eli et al. (2018) The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer. Mol Carcinog 57:182-192
Russ, Atlantis; Hua, Anh B; Montfort, William R et al. (2018) Blocking ""don't eat me"" signal of CD47-SIRP? in hematological malignancies, an in-depth review. Blood Rev 32:480-489

Showing the most recent 10 out of 1336 publications